Abstract:Abstract Background Although the aberrant expression and function of most Ca 2+ -permeable channels are known to promote gastrointestinal tumors, the association between transient receptor potential vanilloid receptor 1 (TRPV1) channels and gastric cancer (GC) has not yet been explored. Herein, we sought to determine the role of TRPV1 channels in the development of GC and to elucidate the underlying molecular mechanisms involved therein. Methods Immunohistochemistry, qPCR, Western blot, immunofluorescence assays were used to detect the mRNA and protein expression of TRPV1 in GC cells and tissues, and the clinical significance of TRPV1 in GC was also studied by clinicopathologic analysis. CCK8, colony formation, flow cytometry assays were used to detect the proliferation and survival of GC cells, while transwell assay was used to detect migration and invasion of GC cells in vitro. Tumor xenograft and peritoneal dissemination assays in nude mice were used to examine the role of TRPV1 in GC development in vivo. Results TRPV1 expression was significantly downregulated in human primary GC tissues compared to their adjacent tissues. The decreased expression of TRPV1 proteins in GC tissues was positively correlated with tumor size, histological grade, lymphatic metastasis, clinical stage, and was strongly correlated with poor prognosis of GC patients. Moreover, the expression of TRPV1 was closely correlated with Ki67, VEGFR, and E-cadherin, all of which are the well-known cancer markers for proliferation and metastasis. TRPV1 proteins were predominately expressed on the plasma membrane in several GC cell lines. TRPV1 overexpression blocked cell cycle at G1 phase to inhibit GC cell proliferation and attenuated migration and invasion of GC cells in vitro, but TRPV1 knockdown increased these parameters. TRPV1 significantly reduced gastric tumor size, number and peritoneal dissemination in vivo. Mechanistically, TRPV1 overexpression in GC cells increased [Ca 2+ ] i , activated CaMKKβ and AMPK phosphorylation, and decreased expression of cyclin D1 and MMP2, while TRPV1 knockdown induced the opposite effects. Conclusions TRPV1 uniquely suppresses GC development through a novel Ca 2+ /CaMKKβ/AMPK pathway and its downregulation is correlated with poor survival of human GC patients. Thus, TRPV1 upregulation and its downstream signaling may represent a promising target for GC prevention and therapy.

The role and mechanism of FoxP3 in biological behavior of gastric cancer cells

FoxP3 Inhibits Proliferation and Induces Apoptosis of Gastric Cancer Cells by Activating the Apoptotic Signaling Pathway

Relationship between forkhead box P3 gene polymorphisms and susceptibility to gastric cancer

High FoxP3 Expression in Tumour Cells Predicts Better Survival in Gastric Cancer and Its Role in Tumour Microenvironment.

The Expression of FoxP3 in Gastric Cancer and Its Interaction with Peripheral Blood Mononuclear Cells (Pbmcs)

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

The FOXO family of transcription factors: key molecular players in gastric cancer

Quantitative Proteomic Analysis Reveals Up-Regulation of Caveolin-1 in FOXP3-overexpressed Human Gastric Cancer Cells

The inhibitory effect of quercetin on chemotherapeutic drug resistance of gastric cancer through forkhead box D3 signaling pathway

Immune infiltration profiling in gastric cancer and their clinical implications

Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway

Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer

MiR-509-3p promotes gastric cancer development by activating FOXM1-mediated p38/MK2 pathway

Identification of functional genes regulating gastric cancer progression using integrated bioinformatics analysis

A 3′-tRNA-derived fragment enhances cell proliferation, migration and invasion in gastric cancer by targeting FBXO47

Study on the Expression of Β-1,3-n-acetylglucosaminyltransferase 3 in Gastric Cancer and the Mechanism Promoting Gastric Cancer Progression Based on the Extraction Method of Nanomagnetic Beads.

Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells

The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway

The role of TRPV1 ion channels in the suppression of gastric cancer development

Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer

FOXN2, identified as a novel biomarker in serum, modulates the transforming growth factor-beta signaling pathway through its interaction with partitioning defective 6 homolog alpha, contributing to the pathogenesis of gastric cancer